The use of cryptocurrency at all the pharmacy’s retail locations will take effect immediately, featuring Ethereum (ETH), Solana (SOL), and XRP (Ripple). As for online payment, these options will be accepted starting Jan 1.
Benefits of cryptocurrency for prescription payments
According to Invictus Pharmacy, accepting cryptocurrency brings a plethora of benefits, including:
- Stronger security: Blockchain provides a highly secure, tamper-resistant environment for transactions, helping to decrease the risk of fraud.
- Quicker processing time: Crypto payments typically move faster than traditional methods, allowing for fulfillment of prescriptions.
- Broader access: The support of cryptocurrency can attract younger or digitally savvy patients who prefer using digital currencies for healthcare purchases.
- Transparency: Each transaction is permanently logged on the blockchain, providing a clear, auditable record in the process.
Invictus Ventures’ broader blockchain strategy
This move by Invictus Pharmacy is only the start of what Invictus Ventures Inc.—the pharmacy’s management company—has in mind. In fact, the company is in the process of designing a blockchain-based payment platform for the US prescription drug market. The system is expected to simplify quick, transparent, and verifiable deals between the various pharma stakeholders, including the payers, manufacturers, pharmacies, and patients.
"Pharmacy benefit managers (PBMs) were invented before the era of the internet to combat rising drug prices in the 1970s," said Meyer Davidoff, Invictus Pharmacy’s founder and CEO. "While their original purpose was to negotiate fair pricing and streamline reimbursements, PBMs have since evolved into powerful intermediaries that obscure true drug costs, delay payments to pharmacies, and inflate prices for patients. The system has become a labyrinth of rebates, clawbacks, and opaque contracts that benefit middlemen rather than patients or providers.
“Today, PBMs act as central toll collectors in a system that should be moving toward openness and modern technology. Accepting cryptocurrency is more than offering another way to pay. It is the first step toward building a faster and more transparent payment network that links patients, pharmacies, and manufacturers with far fewer barriers. This is the future of pharmacy, a system where information and payments move quickly, clearly, and efficiently for everyone."
Alternative drug pricing models remain part of the conversation
However, that is not to say that there are not alternatives to this model that Davidoff referred. Cost Plus Drugs—co-founded by entrepreneur Mark Cuban—strives to provide a cost-plus pricing model (charging the price of the drug plus a 15% markup) providing what many call a transparent alternative to traditional PBMs.2
The Cost Plus Drug website summarizes the concept in saying that, “Our prices are the true cost to get each medication from the manufacturer to you. We cut out the pharmacy middlemen and negotiate directly with manufacturers to get the best possible price. Then, we show you exactly how much you’ll pay for us to keep our business running and how much it will cost to prepare and ship your prescription.”
Crypto payments aim to improve the patient experience
Concerning Invictus Pharmacy, its executives also stressed that integrating cryptocurrency isn’t just a technological upgrade, but rather, it’s also about simplifying the patient experience.
"For our patients, using cryptocurrency will feel just as simple as paying with a smartphone or credit card," said Alan Oustaev, the pharmacy networks’ COO. "Our goal is to make the experience seamless both in-store and online, giving patients more choice and convenience while we modernize how prescription payments are made."
References
1. Invictus Pharmacy First to Accept Crypto for Prescriptions. PR Newswire. November 13, 2025. Accessed November 14, 2025. https://www.prnewswire.com/news-releases/invictus-pharmacy-first-to-accept-crypto-for-prescriptions-302614079.html
2. Saraceno N. Mark Cuban Confirms Cost Plus Drugs Partnership. Pharmaceutical Commerce. October 22, 2025. Accessed November 14, 2025. https://www.pharmaceuticalcommerce.com/view/mark-cuban-confirms-cost-plus-drugs-partnership